References
- 1.CZłONKOWSKA A，LITWIN T，DUSEK P，et al.Wilson disease［J］.Nat Rev Dis Primers，2018，4（1）：21.
- 2.XIE J J，WU Z Y.Wilson's disease in China［J］.Neurosci Bull，2017，33（3）：323-330.
- 3.LI W J，CHEN C，YOU Z F，et al.Current drug managements of Wilson's disease：From west to east［J］.Curr Neuropharmacol，2016，14（4）：322-325.
- 4.SINI M，SORBELLO O，SANNA F，et al.Histologic evolution and long-term outcome of Wilson's disease：Results of a single-center experience［J］.Eur J Gastroenterol Hepatol，2013，25（1）：111-117.
- 5.DONG W，HAO W J，YANG W M，et al.Correlation between liver fibrosis degree and traditional Chinese medicine syndrome type in hepatolenticular degeneration［J］.J Anhui Univ Chinese Med，2023，42（4）：19-23.
- 6.RAO Z H，YANG W M，YANG Y L，et al.Pathogenesis explanation of hepatolenticular degeneration along the "liver-kidney-brain" axis and diagnosis and treatment strategies of traditional Chinese medicine［J］.J Beijing Univ Tradit Chin Med，2025，48（9）：1270-1277.
- 7.GAO Y N，YANG W M，ZHANG J，et al.Clinical features and prognosis of neurological Wilson's disease with different traditional Chinese medicine syndrome types［J］.J Anhui Tradit Chin Med Coll，2025，44（3）：18-22.
- 8.WEI T H，QIAN N N，YANG W M，et al.Clinical characteristics of liver fibrosis in Wilson's disease with different TCM syndrome types based on liver stiffness measurement and multidimensional indicators［J］.Chin J Integr Med Cardio，2022，20（15）：2738-2742.
- 9.TANG L L，CHEN H Z，ZHANG J，et al.Prognostic factor and its predictive value of patients with Wilson's disease-related acute-on-chronic liver failure［J］.Med J Chin PLA，2024，49（2）：131-136.
- 10.Chinese Society of Neurogenetics.Chinese guidelines for the diagnosis and treatment of Wilson's disease 2021［J］.Chin J Neurol，2021，54（4）：310-319.
- 11.TANG L L，YANG W M，WANG H，et al.［C］//The First Affiliated Hospital of Anhui University of Chinese Medicine.Abstract Collection of the First International Conference on Wilson's Disease.The First Affiliated Hospital of Anhui University of Chinese Medicine，2023：3.
- 12.YANG W M，BAO Y C，ZHANG B，et al.Clinical pathway of hepatodendrotoxic nucleus degeneration in TCM［J］.Clin J Tradit Chin Med，2012，24（11）：1127-1129.
- 13.SCHILSKY M L.Wilson disease：Diagnosis，treatment，and follow-up［J］.Clin Liver Dis，2017，21（4）：755-767.
- 14.GEROSA C，FANNI D，CONGIU T，et al.Liver pathology in Wilson's disease：From copper overload to cirrhosis［J］.J Inorg Biochem，2019，193：106-111.
- 15.YANG W M，ZHANG C H，LI R J，et al.Pathogenetic role of poison in Wilson's disease［J］.Chin J Exp Tradit Med Form，2009，15（11）：109-111.
- 16.QIAN N N，YANG W M，WEI T H，et al.Etiology and Pathogenesis of hepatolenticular degeneration caused by latent toxin blocking collaterals［J］.Chin J Exp Tradit Med Form，2022，28（12）：133-140.
- 17.YANG Y ，YANG W M，WANG H，et al.Wilson's disease in traditional Chinese and western medicine：A review［J］.Chin J Exp Tradit Med Form，2024，30（4）：209-217.
- 18.SACLEUX S C，SAMUEL D.A critical review of MELD as a reliable tool for transplant prioritization［J］.Semin Liver Dis，2019，39（4）：403-413.
- 19.BOLIA R，SRIVASTAVA A，YACHHA S K，et al.Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease［J］.J Hepatol，2018，68（3）：449-455.
- 20.BI Z H，WANG L X，LIAN J Q.Definition，prognostic assessment，and advances in the diagnosis and treatment of acute-on-chronic liver failure［J］.J Clin Hepatol，2022，38（7）：1671-1676.
- 21.LUO L，DENG W Y，PENG L，et al.Preliminary study on therapeutic efficacy of plasma exchange in the treatment of patients with liver failure［J］.J Prac Hepatol，2020，23（3）：384-387.
- 22.NIE Q H.Clinical implications of laboratory tests in liver failure and evaluation of new laboratory indices for liver failure［J］.J Clin Hepatol，2013，29（9）：666-669.
- 23.HAO W J，YANG W M，WEI T H，et al.Exploration of the treatment of liver fibrosis in Wilson disease based on the traditional Chinese medicine theory of "micro⁃lumps in liver"［J］.J Beijing Univ Tradit Chin Med，2022，45（3）：307-312.
